| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 8.110.849.094 $ | 99,85 | 184.636.758 | |||||||
| Gilead Sciences, Inc. | Gilead Sciences, Inc. | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 629.354.085 $ | 7,75 | 4.515.707 | |
| Amgen, Inc. | Amgen, Inc. | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 609.808.124 $ | 7,51 | 1.733.148 | |
| Vertex Pharmaceuticals, Inc. | Vertex Pharmaceuticals, Inc. | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 604.629.896 $ | 7,44 | 1.354.033 | |
| Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals, Inc. | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 585.840.372 $ | 7,21 | 758.232 | |
| Alnylam Pharmaceuticals, Inc. | Alnylam Pharmaceuticals, Inc. | EC | 02043Q107 | Long | Börsenkurs (Stufe 1) | 324.134.149 $ | 3,99 | 979.642 | |
| Insmed, Inc. | Insmed, Inc. | EC | 457669307 | Long | Börsenkurs (Stufe 1) | 259.651.282 $ | 3,20 | 1.587.887 | |
| Argenx SE | Argenx SE | EC | 04016X101 | Long | Börsenkurs (Stufe 1) | 249.660.061 $ | 3,07 | 341.883 | |
| Biogen, Inc. | Biogen, Inc. | EC | 09062X103 | Long | Börsenkurs (Stufe 1) | 200.021.463 $ | 2,46 | 1.091.046 | |
| Natera, Inc. | Natera, Inc. | EC | 632307104 | Long | Börsenkurs (Stufe 1) | 196.114.594 $ | 2,41 | 980.622 | |
| United Therapeutics Corp. | United Therapeutics Corp. | EC | 91307C102 | Long | Börsenkurs (Stufe 1) | 187.090.527 $ | 2,30 | 315.509 | |
| BeOne Medicines Ltd. | BeOne Medicines Ltd. | EC | 07725L102 | Long | Börsenkurs (Stufe 1) | 157.139.597 $ | 1,93 | 529.143 | |
| Incyte Corp. | Incyte Corp. | EC | 45337C102 | Long | Börsenkurs (Stufe 1) | 138.160.913 $ | 1,70 | 1.467.923 | |
| Moderna, Inc. | Moderna, Inc. | EC | 60770K107 | Long | Börsenkurs (Stufe 1) | 136.776.917 $ | 1,68 | 2.692.459 | |
| Illumina, Inc. | Illumina, Inc. | EC | 452327109 | Long | Börsenkurs (Stufe 1) | 136.484.689 $ | 1,68 | 1.107.291 | |
| Revolution Medicines, Inc. | Revolution Medicines, Inc. | EC | 76155X100 | Long | Börsenkurs (Stufe 1) | 124.860.442 $ | 1,54 | 1.283.912 | |
| Roivant Sciences Ltd. | Roivant Sciences Ltd. | EC | BMG762791017 | Long | Börsenkurs (Stufe 1) | 100.898.829 $ | 1,24 | 3.642.557 | |
| Neurocrine Biosciences, Inc. | Neurocrine Biosciences, Inc. | EC | 64125C109 | Long | Börsenkurs (Stufe 1) | 95.841.113 $ | 1,18 | 727.502 | |
| Genmab A/S | Genmab A/S | EC | 372303206 | Long | Börsenkurs (Stufe 1) | 95.383.279 $ | 1,17 | 3.555.098 | |
| Bridgebio Pharma, Inc. | Bridgebio Pharma, Inc. | EC | 10806X102 | Long | Börsenkurs (Stufe 1) | 91.984.897 $ | 1,13 | 1.238.687 | |
| Ionis Pharmaceuticals, Inc. | Ionis Pharmaceuticals, Inc. | EC | 462222100 | Long | Börsenkurs (Stufe 1) | 90.524.674 $ | 1,11 | 1.205.549 | |
| Medpace Holdings, Inc. | Medpace Holdings, Inc. | EC | 58506Q109 | Long | Börsenkurs (Stufe 1) | 81.594.845 $ | 1,00 | 169.922 | |
| Madrigal Pharmaceuticals, Inc. | Madrigal Pharmaceuticals, Inc. | EC | 558868105 | Long | Börsenkurs (Stufe 1) | 81.316.353 $ | 1,00 | 155.341 | |
| Exelixis, Inc. | Exelixis, Inc. | EC | 30161Q104 | Long | Börsenkurs (Stufe 1) | 80.261.172 $ | 0,99 | 1.871.326 | |
| BioMarin Pharmaceutical, Inc. | BioMarin Pharmaceutical, Inc. | EC | 09061G101 | Long | Börsenkurs (Stufe 1) | 79.782.522 $ | 0,98 | 1.412.330 | |
| Ascendis Pharma A/S | Ascendis Pharma A/S | EC | 04351P101 | Long | Börsenkurs (Stufe 1) | 77.756.306 $ | 0,96 | 339.948 | |
| Praxis Precision Medicines, Inc. | Praxis Precision Medicines, Inc. | EC | 74006W207 | Long | Börsenkurs (Stufe 1) | 62.858.302 $ | 0,77 | 195.097 | |
| Charles River Laboratories International, Inc. | Charles River Laboratories International, Inc. | EC | 159864107 | Long | Börsenkurs (Stufe 1) | 62.473.463 $ | 0,77 | 362.165 | |
| Arrowhead Pharmaceuticals, Inc. | Arrowhead Pharmaceuticals, Inc. | EC | 04280A100 | Long | Börsenkurs (Stufe 1) | 61.143.473 $ | 0,75 | 975.175 | |
| Vaxcyte, Inc. | Vaxcyte, Inc. | EC | 92243G108 | Long | Börsenkurs (Stufe 1) | 60.765.336 $ | 0,75 | 1.045.695 | |
| Bio-Techne Corp. | Bio-Techne Corp. | EC | 09073M104 | Long | Börsenkurs (Stufe 1) | 60.200.907 $ | 0,74 | 1.151.950 | |
| Cytokinetics, Inc. | Cytokinetics, Inc. | EC | 23282W605 | Long | Börsenkurs (Stufe 1) | 59.119.425 $ | 0,73 | 896.972 | |
| Halozyme Therapeutics, Inc. | Halozyme Therapeutics, Inc. | EC | 40637H109 | Long | Börsenkurs (Stufe 1) | 56.131.284 $ | 0,69 | 868.502 | |
| Axsome Therapeutics, Inc. | Axsome Therapeutics, Inc. | EC | 05464T104 | Long | Börsenkurs (Stufe 1) | 53.932.254 $ | 0,66 | 319.088 | |
| BioNTech SE | BioNTech SE | EC | 09075V102 | Long | Börsenkurs (Stufe 1) | 53.284.093 $ | 0,66 | 599.506 | |
| Krystal Biotech, Inc. | Krystal Biotech, Inc. | EC | 501147102 | Long | Börsenkurs (Stufe 1) | 48.813.697 $ | 0,60 | 188.966 | |
| Protagonist Therapeutics, Inc. | Protagonist Therapeutics, Inc. | EC | 74366E102 | Long | Börsenkurs (Stufe 1) | 47.118.754 $ | 0,58 | 447.047 | |
| Repligen Corp. | Repligen Corp. | EC | 759916109 | Long | Börsenkurs (Stufe 1) | 46.762.287 $ | 0,58 | 396.896 | |
| Kymera Therapeutics, Inc. | Kymera Therapeutics, Inc. | EC | 501575104 | Long | Börsenkurs (Stufe 1) | 43.426.157 $ | 0,53 | 521.385 | |
| Alkermes plc | Alkermes plc | EC | IE00B56GVS15 | Long | Börsenkurs (Stufe 1) | 43.021.168 $ | 0,53 | 1.216.662 | |
| Rhythm Pharmaceuticals, Inc. | Rhythm Pharmaceuticals, Inc. | EC | 76243J105 | Long | Börsenkurs (Stufe 1) | 41.270.657 $ | 0,51 | 474.539 | |
| Abivax SA | Abivax SA | EC | 00370M103 | Long | Börsenkurs (Stufe 1) | 40.916.782 $ | 0,50 | 367.461 | |
| PTC Therapeutics, Inc. | PTC Therapeutics, Inc. | EC | 69366J200 | Long | Börsenkurs (Stufe 1) | 40.411.446 $ | 0,50 | 593.152 | |
| Cogent Biosciences, Inc. | Cogent Biosciences, Inc. | EC | 19240Q201 | Long | Börsenkurs (Stufe 1) | 38.851.652 $ | 0,48 | 1.009.396 | |
| Arcellx, Inc. | Arcellx, Inc. | EC | 03940C100 | Long | Börsenkurs (Stufe 1) | 38.558.163 $ | 0,47 | 335.814 | |
| Terns Pharmaceuticals, Inc. | Terns Pharmaceuticals, Inc. | EC | 880881107 | Long | Börsenkurs (Stufe 1) | 37.634.067 $ | 0,46 | 713.848 | |
| Nuvalent, Inc. | Nuvalent, Inc., Class A | EC | 670703107 | Long | Börsenkurs (Stufe 1) | 36.419.028 $ | 0,45 | 355.481 | |
| Mirum Pharmaceuticals, Inc. | Mirum Pharmaceuticals, Inc. | EC | 604749101 | Long | Börsenkurs (Stufe 1) | 36.275.501 $ | 0,45 | 392.677 | |
| Tempus AI, Inc. | Tempus AI, Inc., Class A | EC | 88023B103 | Long | Börsenkurs (Stufe 1) | 34.996.029 $ | 0,43 | 773.906 | |
| Xenon Pharmaceuticals, Inc. | Xenon Pharmaceuticals, Inc. | EC | 98420N105 | Long | Börsenkurs (Stufe 1) | 34.796.379 $ | 0,43 | 598.390 | |
| Amicus Therapeutics, Inc. | Amicus Therapeutics, Inc. | EC | 03152W109 | Long | Börsenkurs (Stufe 1) | 33.369.704 $ | 0,41 | 2.307.725 | |
| CRISPR Therapeutics AG | CRISPR Therapeutics AG | EC | CH0334081137 | Long | Börsenkurs (Stufe 1) | 31.573.779 $ | 0,39 | 663.733 | |
| Apellis Pharmaceuticals, Inc. | Apellis Pharmaceuticals, Inc. | EC | 03753U106 | Long | Börsenkurs (Stufe 1) | 31.308.796 $ | 0,39 | 778.245 | |
| Apogee Therapeutics, Inc. | Apogee Therapeutics, Inc. | EC | 03770N101 | Long | Börsenkurs (Stufe 1) | 29.755.778 $ | 0,37 | 353.520 | |
| Scholar Rock Holding Corp. | Scholar Rock Holding Corp. | EC | 80706P103 | Long | Börsenkurs (Stufe 1) | 29.187.767 $ | 0,36 | 593.730 | |
| ACADIA Pharmaceuticals, Inc. | ACADIA Pharmaceuticals, Inc. | EC | 004225108 | Long | Börsenkurs (Stufe 1) | 27.852.625 $ | 0,34 | 1.251.241 | |
| Bruker Corp. | Bruker Corp. | EC | 116794108 | Long | Börsenkurs (Stufe 1) | 27.608.033 $ | 0,34 | 764.342 | |
| Crinetics Pharmaceuticals, Inc. | Crinetics Pharmaceuticals, Inc. | EC | 22663K107 | Long | Börsenkurs (Stufe 1) | 26.383.865 $ | 0,32 | 726.428 | |
| CG oncology, Inc. | CG oncology, Inc. | EC | 156944100 | Long | Börsenkurs (Stufe 1) | 25.670.686 $ | 0,32 | 379.295 | |
| Spyre Therapeutics, Inc. | Spyre Therapeutics, Inc. | EC | 00773J202 | Long | Börsenkurs (Stufe 1) | 24.156.170 $ | 0,30 | 478.909 | |
| Erasca, Inc. | Erasca, Inc. | EC | 29479A108 | Long | Börsenkurs (Stufe 1) | 22.399.576 $ | 0,28 | 1.384.399 | |
| Tarsus Pharmaceuticals, Inc. | Tarsus Pharmaceuticals, Inc. | EC | 87650L103 | Long | Börsenkurs (Stufe 1) | 20.871.168 $ | 0,26 | 297.522 | |
| Twist Bioscience Corp. | Twist Bioscience Corp. | EC | 90184D100 | Long | Börsenkurs (Stufe 1) | 20.756.498 $ | 0,26 | 436.795 | |
| Centessa Pharmaceuticals plc | Centessa Pharmaceuticals plc | EC | 152309100 | Long | Börsenkurs (Stufe 1) | 20.684.667 $ | 0,25 | 520.762 | |
| Ideaya Biosciences, Inc. | Ideaya Biosciences, Inc. | EC | 45166A102 | Long | Börsenkurs (Stufe 1) | 20.512.992 $ | 0,25 | 615.636 | |
| Denali Therapeutics, Inc. | Denali Therapeutics, Inc. | EC | 24823R105 | Long | Börsenkurs (Stufe 1) | 20.260.032 $ | 0,25 | 1.055.210 | |
| Travere Therapeutics, Inc. | Travere Therapeutics, Inc. | EC | 89422G107 | Long | Börsenkurs (Stufe 1) | 20.042.366 $ | 0,25 | 674.600 | |
| ImmunityBio, Inc. | ImmunityBio, Inc. | EC | 45256X103 | Long | Börsenkurs (Stufe 1) | 19.732.617 $ | 0,24 | 2.572.701 | |
| Arcutis Biotherapeutics, Inc. | Arcutis Biotherapeutics, Inc. | EC | 03969K108 | Long | Börsenkurs (Stufe 1) | 19.196.193 $ | 0,24 | 814.779 | |
| Veracyte, Inc. | Veracyte, Inc. | EC | 92337F107 | Long | Börsenkurs (Stufe 1) | 18.660.638 $ | 0,23 | 579.343 | |
| Structure Therapeutics, Inc. | Structure Therapeutics, Inc. | EC | 86366E106 | Long | Börsenkurs (Stufe 1) | 18.396.783 $ | 0,23 | 381.676 | |
| Edgewise Therapeutics, Inc. | Edgewise Therapeutics, Inc. | EC | 28036F105 | Long | Börsenkurs (Stufe 1) | 18.024.048 $ | 0,22 | 572.192 | |
| 10X Genomics, Inc. | 10X Genomics, Inc., Class A | EC | 88025U109 | Long | Börsenkurs (Stufe 1) | 17.869.631 $ | 0,22 | 841.716 | |
| Legend Biotech Corp. | Legend Biotech Corp. | EC | 52490G102 | Long | Börsenkurs (Stufe 1) | 17.799.258 $ | 0,22 | 983.928 | |
| Newamsterdam Pharma Co. NV | Newamsterdam Pharma Co. NV | EC | NL00150012L7 | Long | Börsenkurs (Stufe 1) | 17.214.466 $ | 0,21 | 537.784 | |
| Vera Therapeutics, Inc. | Vera Therapeutics, Inc., Class A | EC | 92337R101 | Long | Börsenkurs (Stufe 1) | 16.887.669 $ | 0,21 | 419.778 | |
| Dyne Therapeutics, Inc. | Dyne Therapeutics, Inc. | EC | 26818M108 | Long | Börsenkurs (Stufe 1) | 16.633.731 $ | 0,20 | 917.470 | |
| Beam Therapeutics, Inc. | Beam Therapeutics, Inc. | EC | 07373V105 | Long | Börsenkurs (Stufe 1) | 16.493.315 $ | 0,20 | 692.124 | |
| BioCryst Pharmaceuticals, Inc. | BioCryst Pharmaceuticals, Inc. | EC | 09058V103 | Long | Börsenkurs (Stufe 1) | 16.334.664 $ | 0,20 | 1.715.826 | |
| Kodiak Sciences, Inc. | Kodiak Sciences, Inc. | EC | 50015M109 | Long | Börsenkurs (Stufe 1) | 16.103.070 $ | 0,20 | 422.431 | |
| Sarepta Therapeutics, Inc. | Sarepta Therapeutics, Inc. | EC | 803607100 | Long | Börsenkurs (Stufe 1) | 16.093.848 $ | 0,20 | 739.607 | |
| Caris Life Sciences, Inc. | Caris Life Sciences, Inc. | EC | 142152107 | Long | Börsenkurs (Stufe 1) | 16.056.437 $ | 0,20 | 898.011 | |
| Immunovant, Inc. | Immunovant, Inc. | EC | 45258J102 | Long | Börsenkurs (Stufe 1) | 15.555.081 $ | 0,19 | 626.211 | |
| ADMA Biologics, Inc. | ADMA Biologics, Inc. | EC | 000899104 | Long | Börsenkurs (Stufe 1) | 15.418.263 $ | 0,19 | 1.711.239 | |
| Adaptive Biotechnologies Corp. | Adaptive Biotechnologies Corp. | EC | 00650F109 | Long | Börsenkurs (Stufe 1) | 15.351.238 $ | 0,19 | 1.105.997 | |
| Summit Therapeutics, Inc. | Summit Therapeutics, Inc. | EC | 86627T108 | Long | Börsenkurs (Stufe 1) | 15.158.084 $ | 0,19 | 799.477 | |
| Oruka Therapeutics, Inc. | Oruka Therapeutics, Inc. | EC | 687604108 | Long | Börsenkurs (Stufe 1) | 14.927.436 $ | 0,18 | 304.331 | |
| Syndax Pharmaceuticals, Inc. | Syndax Pharmaceuticals, Inc. | EC | 87164F105 | Long | Börsenkurs (Stufe 1) | 14.752.401 $ | 0,18 | 631.524 | |
| Tango Therapeutics, Inc. | Tango Therapeutics, Inc. | EC | 87583X109 | Long | Börsenkurs (Stufe 1) | 14.390.554 $ | 0,18 | 687.885 | |
| Ultragenyx Pharmaceutical, Inc. | Ultragenyx Pharmaceutical, Inc. | EC | 90400D108 | Long | Börsenkurs (Stufe 1) | 14.251.992 $ | 0,18 | 680.286 | |
| Disc Medicine, Inc. | Disc Medicine, Inc. | EC | 254604101 | Long | Börsenkurs (Stufe 1) | 13.740.003 $ | 0,17 | 214.889 | |
| Agios Pharmaceuticals, Inc. | Agios Pharmaceuticals, Inc. | EC | 00847X104 | Long | Börsenkurs (Stufe 1) | 13.534.943 $ | 0,17 | 400.087 | |
| GRAIL, Inc. | GRAIL, Inc. | EC | 384747101 | Long | Börsenkurs (Stufe 1) | 13.490.806 $ | 0,17 | 261.045 | |
| Definium Therapeutics, Inc. | Definium Therapeutics, Inc. | EC | 24477V105 | Long | Börsenkurs (Stufe 1) | 13.287.267 $ | 0,16 | 703.030 | |
| Zymeworks, Inc. | Zymeworks, Inc. | EC | 98985Y108 | Long | Börsenkurs (Stufe 1) | 13.270.724 $ | 0,16 | 529.981 | |
| Arcus Biosciences, Inc. | Arcus Biosciences, Inc. | EC | 03969F109 | Long | Börsenkurs (Stufe 1) | 13.226.868 $ | 0,16 | 612.355 | |
| Aurinia Pharmaceuticals, Inc. | Aurinia Pharmaceuticals, Inc. | EC | 05156V102 | Long | Börsenkurs (Stufe 1) | 12.957.660 $ | 0,16 | 874.336 | |
| Enliven Therapeutics, Inc. | Enliven Therapeutics, Inc. | EC | 29337E102 | Long | Börsenkurs (Stufe 1) | 12.644.195 $ | 0,16 | 322.556 | |
| Day One Biopharmaceuticals, Inc. | Day One Biopharmaceuticals, Inc. | EC | 23954D109 | Long | Börsenkurs (Stufe 1) | 12.408.893 $ | 0,15 | 578.773 | |
| Vericel Corp. | Vericel Corp. | EC | 92346J108 | Long | Börsenkurs (Stufe 1) | 12.015.559 $ | 0,15 | 373.502 | |
| Mineralys Therapeutics, Inc. | Mineralys Therapeutics, Inc. | EC | 603170101 | Long | Börsenkurs (Stufe 1) | 11.910.064 $ | 0,15 | 439.648 | |
| Alumis, Inc. | Alumis, Inc. | EC | 022307102 | Long | Börsenkurs (Stufe 1) | 11.683.787 $ | 0,14 | 530.358 | |
| Zai Lab Ltd. | Zai Lab Ltd. | EC | 98887Q104 | Long | Börsenkurs (Stufe 1) | 11.544.581 $ | 0,14 | 613.747 | |
| Nurix Therapeutics, Inc. | Nurix Therapeutics, Inc. | EC | 67080M103 | Long | Börsenkurs (Stufe 1) | 11.173.144 $ | 0,14 | 720.848 | |
| Stoke Therapeutics, Inc. | Stoke Therapeutics, Inc. | EC | 86150R107 | Long | Börsenkurs (Stufe 1) | 10.786.737 $ | 0,13 | 331.288 | |
| Intellia Therapeutics, Inc. | Intellia Therapeutics, Inc. | EC | 45826J105 | Long | Börsenkurs (Stufe 1) | 10.709.020 $ | 0,13 | 835.337 | |
| AnaptysBio, Inc. | AnaptysBio, Inc. | EC | 032724106 | Long | Börsenkurs (Stufe 1) | 10.655.863 $ | 0,13 | 192.136 | |
| Recursion Pharmaceuticals, Inc. | Recursion Pharmaceuticals, Inc., Class A | EC | 75629V104 | Long | Börsenkurs (Stufe 1) | 10.498.961 $ | 0,13 | 3.419.857 | |
| Tyra Biosciences, Inc. | Tyra Biosciences, Inc. | EC | 90240B106 | Long | Börsenkurs (Stufe 1) | 10.435.754 $ | 0,13 | 272.474 | |
| Relay Therapeutics, Inc. | Relay Therapeutics, Inc. | EC | 75943R102 | Long | Börsenkurs (Stufe 1) | 9.753.647 $ | 0,12 | 980.266 | |
| Amylyx Pharmaceuticals, Inc. | Amylyx Pharmaceuticals, Inc. | EC | 03237H101 | Long | Börsenkurs (Stufe 1) | 9.556.750 $ | 0,12 | 687.536 | |
| Novavax, Inc. | Novavax, Inc. | EC | 670002401 | Long | Börsenkurs (Stufe 1) | 9.418.908 $ | 0,12 | 1.157.114 | |
| Iovance Biotherapeutics, Inc. | Iovance Biotherapeutics, Inc. | EC | 462260100 | Long | Börsenkurs (Stufe 1) | 9.192.764 $ | 0,11 | 2.619.021 | |
| WaVe Life Sciences Ltd. | WaVe Life Sciences Ltd. | EC | SG9999014716 | Long | Börsenkurs (Stufe 1) | 8.527.349 $ | 0,10 | 1.176.186 | |
| Immunocore Holdings plc | Immunocore Holdings plc | EC | 45258D105 | Long | Börsenkurs (Stufe 1) | 8.357.128 $ | 0,10 | 277.185 | |
| Novocure Ltd. | Novocure Ltd. | EC | JE00BYSS4X48 | Long | Börsenkurs (Stufe 1) | 8.318.891 $ | 0,10 | 763.201 | |
| Galapagos NV | Galapagos NV | EC | 36315X101 | Long | Börsenkurs (Stufe 1) | 8.156.790 $ | 0,10 | 271.893 | |
| Grifols SA | Grifols SA | EC | 398438408 | Long | Börsenkurs (Stufe 1) | 7.828.811 $ | 0,10 | 976.161 | |
| Biohaven Ltd. | Biohaven Ltd. | EC | VGG1110E1079 | Long | Börsenkurs (Stufe 1) | 7.762.346 $ | 0,10 | 917.535 | |
| Nuvation Bio, Inc. | Nuvation Bio, Inc., Class A | EC | 67080N101 | Long | Börsenkurs (Stufe 1) | 7.704.360 $ | 0,09 | 1.795.888 | |
| AtaiBeckley, Inc. | AtaiBeckley, Inc. | EC | 04650F101 | Long | Börsenkurs (Stufe 1) | 7.646.637 $ | 0,09 | 2.160.067 | |
| Taysha Gene Therapies, Inc. | Taysha Gene Therapies, Inc. | EC | 877619106 | Long | Börsenkurs (Stufe 1) | 7.474.645 $ | 0,09 | 1.672.180 | |
| Sionna Therapeutics, Inc. | Sionna Therapeutics, Inc. | EC | 829401108 | Long | Börsenkurs (Stufe 1) | 7.420.699 $ | 0,09 | 185.101 | |
| Trevi Therapeutics, Inc. | Trevi Therapeutics, Inc. | EC | 89532M101 | Long | Börsenkurs (Stufe 1) | 7.259.178 $ | 0,09 | 608.481 | |
| Mesoblast Ltd. | Mesoblast Ltd. | EC | 590717401 | Long | Börsenkurs (Stufe 1) | 7.076.999 $ | 0,09 | 460.143 | |
| Corvus Pharmaceuticals, Inc. | Corvus Pharmaceuticals, Inc. | EC | 221015100 | Long | Börsenkurs (Stufe 1) | 6.924.759 $ | 0,09 | 473.326 | |
| Olema Pharmaceuticals, Inc. | Olema Pharmaceuticals, Inc. | EC | 68062P106 | Long | Börsenkurs (Stufe 1) | 6.825.067 $ | 0,08 | 457.751 | |
| Rapport Therapeutics, Inc. | Rapport Therapeutics, Inc. | EC | 75383L102 | Long | Börsenkurs (Stufe 1) | 6.813.679 $ | 0,08 | 217.759 | |
| uniQure NV | uniQure NV | EC | NL0010696654 | Long | Börsenkurs (Stufe 1) | 6.763.979 $ | 0,08 | 413.699 | |
| Geron Corp. | Geron Corp. | EC | 374163103 | Long | Börsenkurs (Stufe 1) | 6.724.523 $ | 0,08 | 4.513.103 | |
| Fortrea Holdings, Inc. | Fortrea Holdings, Inc. | EC | 34965K107 | Long | Börsenkurs (Stufe 1) | 6.528.597 $ | 0,08 | 693.057 | |
| Vir Biotechnology, Inc. | Vir Biotechnology, Inc. | EC | 92764N102 | Long | Börsenkurs (Stufe 1) | 6.311.863 $ | 0,08 | 704.449 | |
| Xencor, Inc. | Xencor, Inc. | EC | 98401F105 | Long | Börsenkurs (Stufe 1) | 6.190.000 $ | 0,08 | 513.267 | |
| AbCellera Biologics, Inc. | AbCellera Biologics, Inc. | EC | 00288U106 | Long | Börsenkurs (Stufe 1) | 6.044.757 $ | 0,07 | 1.732.022 | |
| MBX Biosciences, Inc. | MBX Biosciences, Inc. | EC | 55287L101 | Long | Börsenkurs (Stufe 1) | 5.958.030 $ | 0,07 | 199.599 | |
| Maze Therapeutics, Inc. | Maze Therapeutics, Inc. | EC | 578784100 | Long | Börsenkurs (Stufe 1) | 5.908.390 $ | 0,07 | 197.936 | |
| CareDx, Inc. | CareDx, Inc. | EC | 14167L103 | Long | Börsenkurs (Stufe 1) | 5.865.701 $ | 0,07 | 337.886 | |
| Theravance Biopharma, Inc. | Theravance Biopharma, Inc. | EC | KYG8807B1068 | Long | Börsenkurs (Stufe 1) | 5.739.772 $ | 0,07 | 353.652 | |
| Monte Rosa Therapeutics, Inc. | Monte Rosa Therapeutics, Inc. | EC | 61225M102 | Long | Börsenkurs (Stufe 1) | 5.698.774 $ | 0,07 | 346.430 | |
| KalVista Pharmaceuticals, Inc. | KalVista Pharmaceuticals, Inc. | EC | 483497103 | Long | Börsenkurs (Stufe 1) | 5.574.319 $ | 0,07 | 276.916 | |
| Janux Therapeutics, Inc. | Janux Therapeutics, Inc. | EC | 47103J105 | Long | Börsenkurs (Stufe 1) | 5.453.651 $ | 0,07 | 392.349 | |
| Pharvaris NV | Pharvaris NV | EC | NL00150005Y4 | Long | Börsenkurs (Stufe 1) | 5.422.898 $ | 0,07 | 191.961 | |
| MannKind Corp. | MannKind Corp. | EC | 56400P706 | Long | Börsenkurs (Stufe 1) | 5.388.483 $ | 0,07 | 2.199.381 | |
| ORIC Pharmaceuticals, Inc. | ORIC Pharmaceuticals, Inc. | EC | 68622P109 | Long | Börsenkurs (Stufe 1) | 5.377.427 $ | 0,07 | 424.422 | |
| Castle Biosciences, Inc. | Castle Biosciences, Inc. | EC | 14843C105 | Long | Börsenkurs (Stufe 1) | 5.295.165 $ | 0,07 | 215.689 | |
| Annexon, Inc. | Annexon, Inc. | EC | 03589W102 | Long | Börsenkurs (Stufe 1) | 5.278.977 $ | 0,06 | 952.884 | |
| UroGen Pharma Ltd. | UroGen Pharma Ltd. | EC | IL0011407140 | Long | Börsenkurs (Stufe 1) | 5.143.017 $ | 0,06 | 286.041 | |
| Kura Oncology, Inc. | Kura Oncology, Inc. | EC | 50127T109 | Long | Börsenkurs (Stufe 1) | 5.109.290 $ | 0,06 | 628.449 | |
| Inhibrx Biosciences, Inc. | Inhibrx Biosciences, Inc. | EC | 45720N103 | Long | Börsenkurs (Stufe 1) | 5.098.387 $ | 0,06 | 75.835 | |
| Stevanato Group SpA | Stevanato Group SpA | EC | IT0005452658 | Long | Börsenkurs (Stufe 1) | 5.092.876 $ | 0,06 | 370.391 | |
| Arbutus Biopharma Corp. | Arbutus Biopharma Corp. | EC | 03879J100 | Long | Börsenkurs (Stufe 1) | 5.037.467 $ | 0,06 | 1.119.437 | |
| Septerna, Inc. | Septerna, Inc. | EC | 81734D104 | Long | Börsenkurs (Stufe 1) | 4.826.305 $ | 0,06 | 200.845 | |
| Alto Neuroscience, Inc. | Alto Neuroscience, Inc. | EC | 02157Q109 | Long | Börsenkurs (Stufe 1) | 4.780.979 $ | 0,06 | 212.677 | |
| Bicara Therapeutics, Inc. | Bicara Therapeutics, Inc. | EC | 055477103 | Long | Börsenkurs (Stufe 1) | 4.711.245 $ | 0,06 | 236.865 | |
| GH Research plc | GH Research plc | EC | IE000GID8VI0 | Long | Börsenkurs (Stufe 1) | 4.698.318 $ | 0,06 | 334.162 | |
| ArriVent Biopharma, Inc. | ArriVent Biopharma, Inc. | EC | 04272N102 | Long | Börsenkurs (Stufe 1) | 4.642.653 $ | 0,06 | 201.242 | |
| CytomX Therapeutics, Inc. | CytomX Therapeutics, Inc. | EC | 23284F105 | Long | Börsenkurs (Stufe 1) | 4.640.766 $ | 0,06 | 987.397 | |
| Cullinan Therapeutics, Inc. | Cullinan Therapeutics, Inc. | EC | 230031106 | Long | Börsenkurs (Stufe 1) | 4.595.926 $ | 0,06 | 323.429 | |
| Replimune Group, Inc. | Replimune Group, Inc. | EC | 76029N106 | Long | Börsenkurs (Stufe 1) | 4.367.615 $ | 0,05 | 570.930 | |
| Precigen, Inc. | Precigen, Inc. | EC | 74017N105 | Long | Börsenkurs (Stufe 1) | 4.275.239 $ | 0,05 | 1.104.713 | |
| Arvinas, Inc. | Arvinas, Inc. | EC | 04335A105 | Long | Börsenkurs (Stufe 1) | 4.272.860 $ | 0,05 | 403.100 | |
| Savara, Inc. | Savara, Inc. | EC | 805111101 | Long | Börsenkurs (Stufe 1) | 4.234.574 $ | 0,05 | 775.563 | |
| Ironwood Pharmaceuticals, Inc. | Ironwood Pharmaceuticals, Inc., Class A | EC | 46333X108 | Long | Börsenkurs (Stufe 1) | 4.118.883 $ | 0,05 | 1.173.471 | |
| Phathom Pharmaceuticals, Inc. | Phathom Pharmaceuticals, Inc. | EC | 71722W107 | Long | Börsenkurs (Stufe 1) | 3.965.659 $ | 0,05 | 356.945 | |
| Zevra Therapeutics, Inc. | Zevra Therapeutics, Inc. | EC | 488445206 | Long | Börsenkurs (Stufe 1) | 3.856.075 $ | 0,05 | 413.742 | |
| Cytek Biosciences, Inc. | Cytek Biosciences, Inc. | EC | 23285D109 | Long | Börsenkurs (Stufe 1) | 3.796.333 $ | 0,05 | 868.726 | |
| MeiraGTx Holdings plc | MeiraGTx Holdings plc | EC | KYG596651029 | Long | Börsenkurs (Stufe 1) | 3.729.368 $ | 0,05 | 430.643 | |
| ARS Pharmaceuticals, Inc. | ARS Pharmaceuticals, Inc. | EC | 82835W108 | Long | Börsenkurs (Stufe 1) | 3.721.134 $ | 0,05 | 463.404 | |
| BioAge Labs, Inc. | BioAge Labs, Inc. | EC | 09077V100 | Long | Börsenkurs (Stufe 1) | 3.696.721 $ | 0,05 | 211.362 | |
| Sana Biotechnology, Inc. | Sana Biotechnology, Inc. | EC | 799566104 | Long | Börsenkurs (Stufe 1) | 3.559.438 $ | 0,04 | 1.235.916 | |
| Rigel Pharmaceuticals, Inc. | Rigel Pharmaceuticals, Inc. | EC | 766559702 | Long | Börsenkurs (Stufe 1) | 3.543.078 $ | 0,04 | 131.031 | |
| Zenas Biopharma, Inc. | Zenas Biopharma, Inc. | EC | 98937L105 | Long | Börsenkurs (Stufe 1) | 3.439.647 $ | 0,04 | 175.941 | |
| Compass Pathways plc | Compass Pathways plc | EC | 20451W101 | Long | Börsenkurs (Stufe 1) | 3.385.190 $ | 0,04 | 612.150 | |
| Fulcrum Therapeutics, Inc. | Fulcrum Therapeutics, Inc. | EC | 359616109 | Long | Börsenkurs (Stufe 1) | 3.293.276 $ | 0,04 | 429.371 | |
| OPKO Health, Inc. | OPKO Health, Inc. | EC | 68375N103 | Long | Börsenkurs (Stufe 1) | 3.286.164 $ | 0,04 | 2.882.600 | |
| Solid Biosciences, Inc. | Solid Biosciences, Inc. | EC | 83422E204 | Long | Börsenkurs (Stufe 1) | 3.215.174 $ | 0,04 | 446.552 | |
| 4D Molecular Therapeutics, Inc. | 4D Molecular Therapeutics, Inc. | EC | 35104E100 | Long | Börsenkurs (Stufe 1) | 3.153.707 $ | 0,04 | 338.744 | |
| Prothena Corp. plc | Prothena Corp. plc | EC | IE00B91XRN20 | Long | Börsenkurs (Stufe 1) | 3.142.952 $ | 0,04 | 323.349 | |
| Emergent BioSolutions, Inc. | Emergent BioSolutions, Inc. | EC | 29089Q105 | Long | Börsenkurs (Stufe 1) | 3.124.975 $ | 0,04 | 376.503 | |
| Myriad Genetics, Inc. | Myriad Genetics, Inc. | EC | 62855J104 | Long | Börsenkurs (Stufe 1) | 2.983.028 $ | 0,04 | 662.895 | |
| Absci Corp. | Absci Corp. | EC | 00091E109 | Long | Börsenkurs (Stufe 1) | 2.925.264 $ | 0,04 | 975.088 | |
| BridgeBio Oncology Therapeutics, Inc. | BridgeBio Oncology Therapeutics, Inc. | EC | 107924102 | Long | Börsenkurs (Stufe 1) | 2.904.391 $ | 0,04 | 324.513 | |
| Perspective Therapeutics, Inc. | Perspective Therapeutics, Inc. | EC | 46489V302 | Long | Börsenkurs (Stufe 1) | 2.891.728 $ | 0,04 | 693.460 | |
| Aclaris Therapeutics, Inc. | Aclaris Therapeutics, Inc. | EC | 00461U105 | Long | Börsenkurs (Stufe 1) | 2.872.545 $ | 0,04 | 766.012 | |
| Altimmune, Inc. | Altimmune, Inc. | EC | 02155H200 | Long | Börsenkurs (Stufe 1) | 2.853.959 $ | 0,04 | 926.610 | |
| Vanda Pharmaceuticals, Inc. | Vanda Pharmaceuticals, Inc. | EC | 921659108 | Long | Börsenkurs (Stufe 1) | 2.798.813 $ | 0,03 | 405.038 | |
| Allogene Therapeutics, Inc. | Allogene Therapeutics, Inc. | EC | 019770106 | Long | Börsenkurs (Stufe 1) | 2.795.196 $ | 0,03 | 1.145.572 | |
| REGENXBIO, Inc. | REGENXBIO, Inc. | EC | 75901B107 | Long | Börsenkurs (Stufe 1) | 2.777.325 $ | 0,03 | 331.423 | |
| Rocket Pharmaceuticals, Inc. | Rocket Pharmaceuticals, Inc. | EC | 77313F106 | Long | Börsenkurs (Stufe 1) | 2.694.190 $ | 0,03 | 752.567 | |
| Pacific Biosciences of California, Inc. | Pacific Biosciences of California, Inc. | EC | 69404D108 | Long | Börsenkurs (Stufe 1) | 2.668.424 $ | 0,03 | 2.021.533 | |
| Lexeo Therapeutics, Inc. | Lexeo Therapeutics, Inc. | EC | 52886X107 | Long | Börsenkurs (Stufe 1) | 2.625.746 $ | 0,03 | 457.447 | |
| Alvotech SA | Alvotech SA | EC | LU2458332611 | Long | Börsenkurs (Stufe 1) | 2.618.740 $ | 0,03 | 763.481 | |
| Contineum Therapeutics, Inc. | Contineum Therapeutics, Inc., Class A | EC | 21217B100 | Long | Börsenkurs (Stufe 1) | 2.616.728 $ | 0,03 | 200.362 | |
| Enanta Pharmaceuticals, Inc. | Enanta Pharmaceuticals, Inc. | EC | 29251M106 | Long | Börsenkurs (Stufe 1) | 2.591.474 $ | 0,03 | 205.184 | |
| Lineage Cell Therapeutics, Inc. | Lineage Cell Therapeutics, Inc. | EC | 53566P109 | Long | Börsenkurs (Stufe 1) | 2.561.859 $ | 0,03 | 1.621.430 | |
| Standard BioTools, Inc. | Standard BioTools, Inc. | EC | 34385P108 | Long | Börsenkurs (Stufe 1) | 2.525.828 $ | 0,03 | 2.747.556 | |
| ADC Therapeutics SA | ADC Therapeutics SA | EC | CH0499880968 | Long | Börsenkurs (Stufe 1) | 2.524.283 $ | 0,03 | 673.142 | |
| Design Therapeutics, Inc. | Design Therapeutics, Inc. | EC | 25056L103 | Long | Börsenkurs (Stufe 1) | 2.509.540 $ | 0,03 | 235.859 | |
| Personalis, Inc. | Personalis, Inc. | EC | 71535D106 | Long | Börsenkurs (Stufe 1) | 2.504.385 $ | 0,03 | 393.153 | |
| Atea Pharmaceuticals, Inc. | Atea Pharmaceuticals, Inc. | EC | 04683R106 | Long | Börsenkurs (Stufe 1) | 2.475.101 $ | 0,03 | 460.056 | |
| Prime Medicine, Inc. | Prime Medicine, Inc. | EC | 74168J101 | Long | Börsenkurs (Stufe 1) | 2.450.240 $ | 0,03 | 704.092 | |
| Keros Therapeutics, Inc. | Keros Therapeutics, Inc. | EC | 492327101 | Long | Börsenkurs (Stufe 1) | 2.371.271 $ | 0,03 | 214.789 | |
| Fulgent Genetics, Inc. | Fulgent Genetics, Inc. | EC | 359664109 | Long | Börsenkurs (Stufe 1) | 2.365.093 $ | 0,03 | 148.748 | |
| Tectonic Therapeutic, Inc. | Tectonic Therapeutic, Inc. | EC | 878972108 | Long | Börsenkurs (Stufe 1) | 2.345.729 $ | 0,03 | 75.889 | |
| Aura Biosciences, Inc. | Aura Biosciences, Inc. | EC | 05153U107 | Long | Börsenkurs (Stufe 1) | 2.262.076 $ | 0,03 | 338.128 | |
| Kyverna Therapeutics, Inc. | Kyverna Therapeutics, Inc. | EC | 501976104 | Long | Börsenkurs (Stufe 1) | 2.168.400 $ | 0,03 | 251.263 | |
| Maravai LifeSciences Holdings, Inc. | Maravai LifeSciences Holdings, Inc., Class A | EC | 56600D107 | Long | Börsenkurs (Stufe 1) | 2.148.117 $ | 0,03 | 759.052 | |
| Immuneering Corp. | Immuneering Corp., Class A | EC | 45254E107 | Long | Börsenkurs (Stufe 1) | 2.055.342 $ | 0,03 | 390.008 | |
| Anavex Life Sciences Corp. | Anavex Life Sciences Corp. | EC | 032797300 | Long | Börsenkurs (Stufe 1) | 2.052.132 $ | 0,03 | 668.447 | |
| Entrada Therapeutics, Inc. | Entrada Therapeutics, Inc. | EC | 29384C108 | Long | Börsenkurs (Stufe 1) | 1.997.330 $ | 0,02 | 158.267 | |
| Ginkgo Bioworks Holdings, Inc. | Ginkgo Bioworks Holdings, Inc. | EC | 37611X209 | Long | Börsenkurs (Stufe 1) | 1.945.190 $ | 0,02 | 317.323 | |
| Upstream Bio, Inc. | Upstream Bio, Inc. | EC | 91678A107 | Long | Börsenkurs (Stufe 1) | 1.917.288 $ | 0,02 | 213.032 | |
| Neurogene, Inc. | Neurogene, Inc. | EC | 64135M105 | Long | Börsenkurs (Stufe 1) | 1.909.031 $ | 0,02 | 94.694 | |
| LENZ Therapeutics, Inc. | LENZ Therapeutics, Inc. | EC | 52635N103 | Long | Börsenkurs (Stufe 1) | 1.893.785 $ | 0,02 | 206.971 | |
| Autolus Therapeutics plc | Autolus Therapeutics plc | EC | 05280R100 | Long | Börsenkurs (Stufe 1) | 1.823.920 $ | 0,02 | 1.321.681 | |
| Editas Medicine, Inc. | Editas Medicine, Inc. | EC | 28106W103 | Long | Börsenkurs (Stufe 1) | 1.805.973 $ | 0,02 | 731.163 | |
| Cabaletta Bio, Inc. | Cabaletta Bio, Inc. | EC | 12674W109 | Long | Börsenkurs (Stufe 1) | 1.703.720 $ | 0,02 | 633.353 | |
| C4 Therapeutics, Inc. | C4 Therapeutics, Inc. | EC | 12529R107 | Long | Börsenkurs (Stufe 1) | 1.601.247 $ | 0,02 | 608.839 | |
| Larimar Therapeutics, Inc. | Larimar Therapeutics, Inc. | EC | 517125100 | Long | Börsenkurs (Stufe 1) | 1.576.868 $ | 0,02 | 350.415 | |
| Candel Therapeutics, Inc. | Candel Therapeutics, Inc. | EC | 137404109 | Long | Börsenkurs (Stufe 1) | 1.445.476 $ | 0,02 | 294.995 | |
| Arcturus Therapeutics Holdings, Inc. | Arcturus Therapeutics Holdings, Inc. | EC | 03969T109 | Long | Börsenkurs (Stufe 1) | 1.443.385 $ | 0,02 | 186.967 | |
| OmniAb, Inc. | OmniAb, Inc. | EC | 68218J103 | Long | Börsenkurs (Stufe 1) | 1.372.411 $ | 0,02 | 874.147 | |
| NovaBridge Biosciences | NovaBridge Biosciences | EC | 44975P103 | Long | Börsenkurs (Stufe 1) | 1.327.214 $ | 0,02 | 539.518 | |
| Voyager Therapeutics, Inc. | Voyager Therapeutics, Inc. | EC | 92915B106 | Long | Börsenkurs (Stufe 1) | 1.270.106 $ | 0,02 | 329.043 | |
| AC Immune SA | AC Immune SA | EC | CH0329023102 | Long | Börsenkurs (Stufe 1) | 1.219.455 $ | 0,02 | 443.438 | |
| Bicycle Therapeutics plc | Bicycle Therapeutics plc | EC | 088786108 | Long | Börsenkurs (Stufe 1) | 1.132.629 $ | 0,01 | 244.101 | |
| Caribou Biosciences, Inc. | Caribou Biosciences, Inc. | EC | 142038108 | Long | Börsenkurs (Stufe 1) | 1.129.520 $ | 0,01 | 594.484 | |
| Codexis, Inc. | Codexis, Inc. | EC | 192005106 | Long | Börsenkurs (Stufe 1) | 1.113.970 $ | 0,01 | 683.417 | |
| Lyell Immunopharma, Inc. | Lyell Immunopharma, Inc. | EC | 55083R203 | Long | Börsenkurs (Stufe 1) | 1.091.525 $ | 0,01 | 54.413 | |
| Cellectis SA | Cellectis SA | EC | 15117K103 | Long | Börsenkurs (Stufe 1) | 1.077.397 $ | 0,01 | 339.873 | |
| Foghorn Therapeutics, Inc. | Foghorn Therapeutics, Inc. | EC | 344174107 | Long | Börsenkurs (Stufe 1) | 1.066.848 $ | 0,01 | 223.190 | |
| Quanterix Corp. | Quanterix Corp. | EC | 74766Q101 | Long | Börsenkurs (Stufe 1) | 1.002.591 $ | 0,01 | 284.827 | |
| Sagimet Biosciences, Inc. | Sagimet Biosciences, Inc., Class A | EC | 786700104 | Long | Börsenkurs (Stufe 1) | 988.502 $ | 0,01 | 189.187 | |
| Quantum-Si, Inc. | Quantum-Si, Inc. | EC | 74765K105 | Long | Börsenkurs (Stufe 1) | 947.015 $ | 0,01 | 1.223.534 | |
| Silence Therapeutics plc | Silence Therapeutics plc | EC | 82686Q101 | Long | Börsenkurs (Stufe 1) | 913.360 $ | 0,01 | 173.313 | |
| Tenaya Therapeutics, Inc. | Tenaya Therapeutics, Inc. | EC | 87990A106 | Long | Börsenkurs (Stufe 1) | 830.881 $ | 0,01 | 1.200.002 | |
| Neumora Therapeutics, Inc. | Neumora Therapeutics, Inc. | EC | 640979100 | Long | Börsenkurs (Stufe 1) | 821.789 $ | 0,01 | 421.430 | |
| PepGen, Inc. | PepGen, Inc. | EC | 713317105 | Long | Börsenkurs (Stufe 1) | 798.859 $ | 0,01 | 451.333 | |
| Humacyte, Inc. | Humacyte, Inc. | EC | 44486Q103 | Long | Börsenkurs (Stufe 1) | 741.460 $ | 0,01 | 1.222.120 | |
| Black Diamond Therapeutics, Inc. | Black Diamond Therapeutics, Inc. | EC | 09203E105 | Long | Börsenkurs (Stufe 1) | 684.884 $ | 0,01 | 321.542 | |
| Pyxis Oncology, Inc. | Pyxis Oncology, Inc. | EC | 747324101 | Long | Börsenkurs (Stufe 1) | 503.890 $ | 0,01 | 345.130 | |
| Gossamer Bio, Inc. | Gossamer Bio, Inc. | EC | 38341P102 | Long | Börsenkurs (Stufe 1) | 496.211 $ | 0,01 | 1.510.536 | |
| Jyong Biotech Ltd. | Jyong Biotech Ltd. | EC | KYG831161065 | Long | Börsenkurs (Stufe 1) | 443.973 $ | 0,01 | 206.499 | |
| Aardvark Therapeutics, Inc. | Aardvark Therapeutics, Inc. | EC | 002942100 | Long | Börsenkurs (Stufe 1) | 338.101 $ | 0,00 | 89.682 | |
| Immutep Ltd. | Immutep Ltd. | EC | 45257L108 | Long | Börsenkurs (Stufe 1) | 284.045 $ | 0,00 | 809.244 | |
| Alpha Teknova, Inc. | Alpha Teknova, Inc. | EC | 02080L102 | Long | Börsenkurs (Stufe 1) | 230.148 $ | 0,00 | 79.636 | |
| Third Harmonic Bio, Inc. | Third Harmonic Bio, Inc. | EC | 88427A107 | Long | Schätzwert (Stufe 3) | 1 $ | 0,00 | 134.478 | |
| 8.110.849.094 $ | 99,85 | 184.636.758 |
Keine Anlageberatung, keine individuelle Empfehlung.
Die hier gezeigten Zahlen sind eine aggregierte Auswertung öffentlich zugänglicher
SEC-Meldungen und stellen keine Bewertung oder Empfehlung zu einzelnen Wertpapieren,
Fonds oder Emittenten dar.
Interessenkonflikte: Der Betreiber kann über verlinkte Anbieter (z. B. Broker) Affiliate-Vergütungen erhalten und ggf. eigene Positionen in genannten Werten halten. Methodik: Berechnungsgrundlagen.
Interessenkonflikte: Der Betreiber kann über verlinkte Anbieter (z. B. Broker) Affiliate-Vergütungen erhalten und ggf. eigene Positionen in genannten Werten halten. Methodik: Berechnungsgrundlagen.
Keine Anlageberatung, keine individuelle Empfehlung.
Aggregierte Auswertung öffentlicher SEC-Meldungen, keine Bewertung einzelner
Wertpapiere. Der Betreiber kann über verlinkte Anbieter Affiliate-Vergütungen
erhalten und ggf. eigene Positionen halten.
Rechtliche Hinweise.